Back

The use of intravenous albumin in decongestion of acutely decompensated heart failure-diorasis trial, early outcomes

11 May 2024 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: ePosters in interventional cardiology and pharmacology 2 Diuretics HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Mr Marios Vasileios Koutroulos

General University Hospital of Alexandroupolis, Alexandroupolis (Greece)

6 More presentations in this session

Presentation thumbnail
Challenging the norm: the use of sublingual nitroglycerin in patients with severe aortic stenosis undergoing cardiac CT
Doctor A. Silva (Coimbra, PT)
Abstract Slides Video
Presentation thumbnail
Age differences in prescribing guideline-directed medical treatment in heart failure with mildly reduced and reduced ejection fraction
Doctor V. Lopes (Coimbra, PT)
Abstract Slides Video
Presentation thumbnail
Adherence to the guideline-directed medical therapy in chronic heart failure: insight from a University Hospital
Doctor M. Assamti (Oujda, MA)
Abstract Slides Video
Presentation thumbnail
Prescribing SGLT2 inhibitors in acute heart failure: considerations for dysglycemia status, heart failure phenotype, and kidney function
Doctor A. Amanova (Aktobe, KZ)
Abstract Slides Video
Presentation thumbnail
Use of SGLT2 inhibitors in real life: predicting left ventricular reverse remodelling.
Doctor V. De Simone (Legnago, IT)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in interventional cardiology and pharmacology 2

The Event

Event poster

Heart Failure 2024

11 May - 14 May 2024
You may be interested in
thumbnail
Congress Presentation
Different loop diuretic dosing and administration in acute Heart Failure (DIUR-AHF): effects on congestion renal function and outcome
thumbnail
Congress Presentation
Thoracic fluid content as a marker of high intravenous diuretic requirements in patients hospitalized for heart failure decompensation
thumbnail
Congress Presentation
Albumin is one of the most important prognostic predictors in heart failure with reduced ejection fraction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources